ARCHIVES

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990

Institutions Fail To Credit NIH when Patenting discoveries, HHS Says

July 15, 1994

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.

February 25, 2000

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002

NCI to release RFP for Cancer Information Service recompetition.

November 28, 2003